MACQUARIE GROUP LTD - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 204 filers reported holding REGENXBIO INC in Q3 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$2,453,000
-17.7%
149,0000.0%0.00%0.0%
Q2 2023$2,979,000
+5.7%
149,0000.0%0.00%0.0%
Q1 2023$2,818,000
-16.6%
149,0000.0%0.00%
-25.0%
Q4 2022$3,379,000
-14.8%
149,000
-0.2%
0.00%
-20.0%
Q3 2022$3,967,000
+7.0%
149,332
-0.5%
0.01%
+25.0%
Q2 2022$3,707,000
-25.6%
150,0910.0%0.00%0.0%
Q1 2022$4,981,000
+1.5%
150,0910.0%0.00%0.0%
Q4 2021$4,908,000
-22.0%
150,0910.0%0.00%
-20.0%
Q3 2021$6,292,000
+7.1%
150,091
-0.8%
0.01%0.0%
Q2 2021$5,876,000
+14.9%
151,246
+0.9%
0.01%
-28.6%
Q1 2021$5,114,000
-25.0%
149,941
-0.2%
0.01%
-30.0%
Q4 2020$6,815,000
+64.9%
150,2300.0%0.01%
+42.9%
Q3 2020$4,134,000
-25.3%
150,2300.0%0.01%
-30.0%
Q2 2020$5,533,000
+14.7%
150,230
+0.8%
0.01%0.0%
Q1 2020$4,825,000
-21.0%
149,0000.0%0.01%
+11.1%
Q4 2019$6,105,000
+15.1%
149,0000.0%0.01%0.0%
Q3 2019$5,304,000
-76.9%
149,000
-66.7%
0.01%
-30.8%
Q2 2019$22,962,000
+168.9%
447,000
+200.0%
0.01%
-13.3%
Q1 2019$8,539,000
+36.6%
149,0000.0%0.02%
+25.0%
Q4 2018$6,251,000
-44.4%
149,0000.0%0.01%
-33.3%
Q3 2018$11,250,000
+5.2%
149,0000.0%0.02%0.0%
Q2 2018$10,691,000
+140.4%
149,0000.0%0.02%
+125.0%
Q1 2018$4,448,000149,0000.01%
Other shareholders
REGENXBIO INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders